These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12183004)

  • 1. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
    Grabenbauer GG; Sauer R
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
    Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
    Bentzen SM; Bernier J
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
    Budach V; Stuschke M; Budach W; Baumann M; Geismar D; Grabenbauer G; Lammert I; Jahnke K; Stueben G; Herrmann T; Bamberg M; Wust P; Hinkelbein W; Wernecke KD
    J Clin Oncol; 2005 Feb; 23(6):1125-35. PubMed ID: 15718308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity.
    Henk JM
    Clin Oncol (R Coll Radiol); 1997; 9(5):308-12. PubMed ID: 9368726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of accelerated hyperfractionation for head and neck cancer.
    Cummings BJ
    Acta Oncol; 1999; 38(2):131-6. PubMed ID: 10227432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR
    J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
    Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma.
    Abitbol AA; Sridhar KS; Lewin AA; Schwade JG; Raub W; Wolfson A; Gonzalez-Angulo C; Adessa A; Goodwin WJ; Markoe AM
    Cancer; 1997 Jul; 80(2):266-76. PubMed ID: 9217040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
    Semrau R; Mueller RP; Stuetzer H; Staar S; Schroeder U; Guntinas-Lichius O; Kocher M; Eich HT; Dietz A; Flentje M; Rudat V; Volling P; Schroeder M; Eckel HE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1308-16. PubMed ID: 16464538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
    Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
    Logie MB
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperfractionated irradiation with simultaneous cisplatin chemotherapy in patients with far-advanced carcinoma of the head and neck].
    Glanzmann C; Sartorelli B; Thum P; Lütolf UM
    Strahlenther Onkol; 1990 Jun; 166(6):397-401. PubMed ID: 2194304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In regard to Suntharalingam et al. IJROBP 2000;47(1):49-56.
    Ochel H
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):281-2. PubMed ID: 11163527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.